Core Laboratories Inc (CLB) Stock Analysis
Verdict: WATCH (do not buy)
Structural revenue stagnation and a massive recent earnings miss (45%) offset tailwinds from long-cycle reservoir analysis demand.
Investment score: 42/100
Analysis as of
Is Core Laboratories Inc stock worth reviewing? The TradeMates thesis
Core Labs is struggling with stagnant growth and poor earnings execution, making current valuation unattractive despite recent price declines.
7-factor investment score
- Valuation: 55/100 (weight 20%)
- Financial Health: 40/100 (weight 15%)
- Technical Momentum: 25/100 (weight 15%)
- Earnings Quality: 35/100 (weight 15%)
- Insider Sentiment: 50/100 (weight 10%)
- Analyst Consensus: 30/100 (weight 10%)
- Risk-Adjusted Return: 48/100 (weight 15%)
Core Laboratories Inc opportunities and risks
What speaks for CLB
- Long-cycle reservoir demand
What speaks against CLB
- Earnings Unpredictability
Peers and competitors
- SBMO.AS
Frequently asked questions about Core Laboratories Inc (CLB)
Is CLB stock a good investment?
The TradeMates model rates Core Laboratories Inc as WATCH (do not buy) with an investment score of 42/100. Core Labs is struggling with stagnant growth and poor earnings execution, making current valuation unattractive despite recent price declines. This is algorithmic model output, not personal investment advice.
Is CLB stock a buy?
The TradeMates model verdict for CLB is WATCH (do not buy) with an investment score of 42/100. Treat this as a model signal to review, not a personal buy recommendation.